Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Green Cross (006280 KS)
Watchlist
92
Analysis
Health Care
•
South Korea
Green Cross Corporation manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SillaJen Inc
•
29 Nov 2016 05:36
SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year
We need to examine the size of SillaJen's expected sales in 2020, which is the reference year for its entire valuation. With an assumption that...
Sanghyun Park
Follow
292 Views
Share
bullish
•
SillaJen Inc
•
26 Nov 2016 03:48
SillaJen IPO Part 4 - IPO Price & Post-IPO Risks
SillaJen IPO price was set at ₩15,000, the lowest end of the indicative price band, after conducting the demand survey from (Nov 23-24) the...
Sanghyun Park
Follow
284 Views
Share
bullish
•
SillaJen Inc
•
21 Nov 2016 13:33
SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)
* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...
Sanghyun Park
Follow
249 Views
Share
bullish
•
SillaJen Inc
•
03 Nov 2016 11:26
SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
Sanghyun Park
Follow
253 Views
Share
bullish
•
SillaJen Inc
•
02 Nov 2016 15:20
SillaJen IPO Part 1 - Schedule, Financials & Valuation
SillaJen Biotherapeutics (established in 2006) submitted the IPO report. The company develops potent multi-functional immunotherapeutics for...
Sanghyun Park
Follow
352 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x